Health data company Innovaccer scooped up $150 million in Series E funding, bumping the company’s valuation to $3.2 billion, Mobi Health News reports.
The round, which follows a $105 million Series D from February this year, was led by Mubadala Capital, with participation from B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners and Schonfeld Strategic Advisors.
Founded in 2014, Innovaccer said the company’s total raise is now more than $375 million. The new capital will go toward research and development, and talent recruitment. Read more.
